2HA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spero Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.9065 EUR -4.07% Market Closed

Market Cap: €1.5m

S	Spero Therapeutics Inc F:2HA	US
S	Stagwell Inc F:6IY	US
	Infineon Technologies AG OTC:IFNNF	DE
B	Banco Santander SA XMUN:BSD2	ES
C	Compagnie de Saint Gobain SA XMUN:GOB	FR
	Mindteck (India) Ltd NSE:MINDTECK	IN
C	Cambridge Capital Holdings Inc OTC:CCHI	US
Y	Yamuna Syndicate Ltd BSE:540980	IN
	Super League Enterprise Inc NASDAQ:SLE	US
	Figeac Aero SARL F:1F1	FR
	Pieris Pharmaceuticals Inc F:PI6	US
F	Famon Awal Bros Sedaya Tbk PT IDX:PRAY	ID

Profitability Summary

Spero Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

14%

Negative 3Y Average Operating Margin

-40%

Operating Margin is Increasing

3% > 14%

Healthy Net Margin

16%

Negative 3Y Average Net Margin

-37%

Net Margin is Increasing

-2% > 16%

Exceptional Free Cash Flow Margin

42%

Negative 3Y Average Free Cash Flow Margin

-27%

Free Cash Flow Margin is Increasing

37% > 42%

Positive ROE

19%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-20%

ROIC is Increasing

-48% > 41%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.